The development of targeted medicine has greatly expanded treatment options and spurred
new research avenues in cancer therapeutics, with monoclonal antibodies (mAbs) emerging …

The recent outbreak of the betacoronavirus SARS-CoV-2 has become a significant concern
to public health care worldwide. As of August 19, 2020, more than 22,140,472 people are …

Precise and effective manipulation of protein functions still faces tremendous challenges.
Herein we report a programmable peptide molecule, consisted of targeting and self …

The crucial role of the immune system in the progression/regression of breast cancer (BC)
should always be taken into account. Various immunotherapy approaches have been …

Immunotherapy has been well regarded as one of the safer and antigen-specific anti-cancer
treatments compared to first-generation chemotherapy. Since Coley's discovery, researchers …

The immune system is essential in recognizing and eliminating tumor cells. The unique
characteristics of the tumor microenvironment (TME), such as heterogeneity, reduced blood …

Breast cancer is the most common type of cancer in women and the second leading cause
of cancer death in female. Triple-negative breast cancer has a more aggressive proliferation …

The development of Immune checkpoint blockade (ICB) therapy and BRAF-and MEK-
targeted therapies has reshaped the survival outcomes of the patients with advanced …

Solid cancers are affiliate on angiogenesis for preservation. The FDA-approved monoclonal
antibodies like Bevacizumab are currently being administered effectively as inhibitors of …

Purpose. Prognostic significance and gene signatures associated with carbonic anhydrase
IX (CAIX) was investigated in triple negative breast cancer (TNBC) patients. Methods …